research

Health Isabella Cueto

What’s in a drink? U.S. regulators consider new alcohol label, but health advocates want even more

Health Meghana Keshavan

STAT Plus: Three MDMA therapy papers retracted over ethics violations

First Opinion Susannah Baruch

Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health

Morning Rounds Brittany Trang

Morning Rounds: Another Ebola outbreak?

First Opinion Anne N. Thorndike

Small changes in food ‘choice environments’ in stores can make a healthy difference

The Readout Meghana Keshavan

STAT Plus: Why did Novo pull heart failure paperwork for Wegovy?

Health Rohan Rajeev

How experiencing famine in the womb may shape people’s health as adults

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: A strong start for Madrigal’s MASH drug launch

The Readout Meghana Keshavan

STAT Plus: Sarepta CEO: We’re ‘pretty brilliant’

Health Angus Chen

Scientists are starting to uncover how neighborhood can affect the biology of cancer

The Readout Elaine Chen

STAT Plus: A new drug for glioma means a windfall for Agios

The Readout Elaine Chen

STAT Plus: The exclusive biotech stories you need to read

First Opinion David Blumenthal and Sara Rosenbaum

Congress is unprepared for the post-Chevron world. It needs help from subject matter experts

First Opinion Sanjay Basu

Cost-effectiveness of health interventions may be perpetuating health disparities. Here’s how to fix that

The Readout Meghana Keshavan

STAT Plus: FDA ad comm favors Zevra’s Niemann-Pick drug

First Opinion Jeffrey S. Flier

Diversity statements should not be required for federal STEMM grant funding

First Opinion John P. Moore

The coronavirus lab leak hypothesis is damaging science

The Readout Elaine Chen

STAT Plus: Moderna is still in a Covid hangover

First Opinion Amy West

ACL tears in women: Too many injuries and too little research

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: On Andrew Left and the government’s fraud case

The Readout Elaine Chen

STAT Plus: venBio raises $528 million for its fifth fund

In the Lab Angus Chen

STAT Plus: With Biden’s departure in sight, advocates seek to preserve gains of Cancer Moonshot

Morning Rounds Theresa Gaffney

Morning Rounds: Grindr gets into health care lobbying

The Readout Elaine Chen

STAT Plus: The debate over how long to use Alzheimer’s drugs

A STAT Investigation Katherine Eban

Mount Sinai mounted aggressive campaign to stifle debate over revelations about its controversial brain research

The Readout Elaine Chen

STAT Plus: Testing GLP-1s in Alzheimer’s, and is Medicare a good negotiator?

Health Theresa Gaffney

There’s more data for trans people with HIV than any other disease — but it’s still flawed

In the Lab Alia Sajani

STAT Plus: Parasite engineered to treat brain development disorder in mice shows potential in study

Health Elizabeth Cooney

New cardiovascular risk model could greatly decrease use of statins and increase heart attacks, study warns